Colin-Bracamontes, Ignacio
Pérez-Calatayud, Ángel Augusto
Carrillo-Esper, Raúl
Rodríguez-Ayala, Ernesto
Padilla-Molina, Misael
Posadas-Nava, Alejandro
Olvera-Vázquez, Susana
Hernández-Salgado, Lidia
Article History
First Online: 25 March 2020
Compliance with Ethical Standards
:
: Funding was provided by the Pharmaceutical Laboratory LFB Mexico, SAPI de CV.
: IC and SO are full-time employees at the Pharmaceutical Laboratory LFB Mexico, SAPI de CV. LH is a full-time employee at Innovare R&D in the Pharmacovigilance Coordination Department. AC, RC, MP, and AP are currently speakers for LFB Mexico, but no further conflicts of interest have been established.
: This study was performed in compliance with Good Clinical Practices, the 1964 Helsinki Declaration and its amendments, and with the national regulations in force. The Nuremberg Code of Ethics was also followed. The study is considered as a minimal risk research. Following the ethical standards of the National Pharmacovigilance Committee, this study and its written consent were evaluated and approved under the code CNFV/PCT/145/2014.
: Written consent was approved by all participating physicians who reported safety information for the elaboration of this study.